CSIMarket
 


Kymera Therapeutics Inc   (KYMR)
Other Ticker:  
 
 

KYMR's Free Cash Flow Growth by Quarter and Year

Kymera Therapeutics Inc 's Free Cash Flow results by quarter and year




KYMR Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -37.26 108.20 0.00
III Quarter September -34.27 -30.51 0.00 0.00
II Quarter June -38.99 -22.82 0.00 0.00
I Quarter March -40.30 -20.07 0.00 0.00
FY   -113.56 -110.66 108.20 0.00



KYMR Free Cash Flow third quarter 2022 Y/Y Growth Comment
Kymera Therapeutics Inc in the third quarter 2022 recorded free cash outflow of $ -34.27 millions.

According to the results reported in the third quarter 2022, Kymera Therapeutics Inc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Kymera Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2022.




KYMR Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kymera Therapeutics Inc 's third quarter 2022 Free Cash Flow $ -34.27 millions KYMR's Income Statement
Kymera Therapeutics Inc 's third quarter 2021 Free Cash Flow $ -30.51 millions Quarterly KYMR's Income Statement
New: More KYMR's historic Free Cash Flow Growth >>


KYMR Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kymera Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's III. Quarter Q/Q Free Cash Flow Comment
Even if Kymera Therapeutics Inc in the III. Quarter 2022 revealed free cash outflow of $ -34.27 millions, management mentioned, that those numbers are recovery relative to the -38.99 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Kymera Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Kymera Therapeutics Inc in the III. Quarter 2022 admitted free cash outflow of $ -34.27 millions, it should be point out, that those numbers show recovery compare to the -38.99 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Kymera Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Kymera Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Free Cash Flow 12 Months Ending $ -148.04 $ -144.90 $ -129.31 $ -108.13 $ -52.54
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Kymera Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -148 millions in the Sep 30 2022 period.
The situation is worsening as the cumulative free cash outflow is inflating from $ -144.9 millions in TTM ending quarter Jun 30 2022 and $ -38.99 millions for the twelve months ending in the quarter a year ago.

Kymera Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Kymera Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -148 millions in the Sep 30 2022 period.
The situation is detiriorating as the cumulative free cash outflow is getting bigger from $ -144.9 millions in TTM ending quarter Jun 30 2022 and $ -38.99 millions for the twelve months ending in the quarter Jun 30 2021 Emanuel Coelho told.

Kymera Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
KYMR's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for KYMR's Competitors
Free Cash Flow Growth for Kymera Therapeutics Inc 's Suppliers
Free Cash Flow Growth for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Dividend Payout Ratio
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2022
Conmed Corporation21.21%$ 21.211 millions
Dexcom Inc 18.56%$ 18.560 millions
Merck and Co Inc 16.78%$ 16.781 millions
Iradimed Corporation16.58%$ 16.580 millions
Incyte Corporation16.18%$ 16.183 millions
Bio techne Corp15.79%$ 15.788 millions
National Research Corporation15.46%$ 15.464 millions
Royalty Pharma Plc14.70%$ 14.703 millions
Community Health Systems Inc 14.17%$ 14.167 millions
Amneal Pharmaceuticals Inc 13.61%$ 13.605 millions
Vericel Corporation12.85%$ 12.851 millions
Owens and Minor Inc 11.54%$ 11.543 millions
Pactiv Evergreen Inc 10.29%$ 10.294 millions
Pro dex Inc 7.07%$ 7.071 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BIOR's Profile

Stock Price

BIOR's Financials

Business Description

Fundamentals

Charts & Quotes

BIOR's News

Suppliers

BIOR's Competitors

Customers & Markets

Economic Indicators

BIOR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071